Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Dr Agarwals Health
Join Channel
Consolidated Standalone

Dr. Agarwal's Health

₹498.6 -4.8 | 1%

Market Cap ₹15764 Cr.

Stock P/E 142.9

P/B 8.2

Current Price ₹498.6

Book Value ₹ 61.1

Face Value 1

52W High ₹567.8

Dividend Yield 0%

52W Low ₹ 327.4

Edit Ratio

Dr. Agarwal's Health Research see more...

Overview Inc. Year: 2010Industry: Hospital & Healthcare Services

​Dr. Agarwal’s Health Care Ltd (DAHCL), established in 2010 and headquartered in Chennai, is India’s largest eye care service provider.The company offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceuticals. The company employs a scalable, asset-light hub-and-spoke model, with 28 tertiary hubs (including three Centers of Excellence) and 165 primary and secondary spokes across 14 states and four union territories in India. Internationally, DAHCL has expanded its presence with 16 facilities across nine African countries. The company is recognized for its clinical excellence, driven by a strong clinical board and a history of surgical innovations. Doctor-promoters lead a team of qualified medical professionals supported by experienced management.

Read More..

Dr. Agarwal's Health Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Dr. Agarwal's Health Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 333 349 403 417 431 460 487 499
Other Income 12 20 6 12 13 15 13 8
Total Income 345 369 409 428 443 476 501 507
Total Expenditure 244 242 300 310 316 329 360 363
Operating Profit 101 127 110 119 128 146 141 144
Interest 22 27 27 28 28 25 25 23
Depreciation 43 46 56 57 58 60 63 68
Exceptional Income / Expenses 0 0 0 0 0 -3 0 0
Profit Before Tax 36 54 27 33 41 59 54 54
Provision for Tax 13 13 9 12 13 16 16 17
Profit After Tax 23 41 18 21 28 43 38 36
Adjustments -3 -3 -6 -5 -6 -10 -8 -7
Profit After Adjustments 20 39 12 17 22 33 30 30
Adjusted Earnings Per Share 0.7 1.4 0 0.5 0.7 1 1 0.9

Dr. Agarwal's Health Profit & Loss

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 531 471 696 1018 1332 1711 1877
Other Income 13 14 22 18 49 57 49
Total Income 544 485 718 1036 1382 1768 1927
Total Expenditure 407 394 514 748 970 1260 1368
Operating Profit 136 90 203 288 411 509 559
Interest 54 44 49 76 101 115 101
Depreciation 93 95 98 128 170 231 249
Exceptional Income / Expenses 0 0 0 0 0 -3 -3
Profit Before Tax -11 -48 57 84 141 160 208
Provision for Tax 9 10 14 -20 46 50 62
Profit After Tax -20 -58 43 103 95 110 145
Adjustments -1 3 -5 -9 -12 -27 -31
Profit After Adjustments -21 -55 38 94 83 83 115
Adjusted Earnings Per Share -1 -2.7 1.8 4 3 2.6 3.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 28% 35% 26% 0%
Operating Profit CAGR 24% 36% 30% 0%
PAT CAGR 16% 37% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 7% 14% 7% 5%
ROCE Average 14% 18% 15% 15%

Dr. Agarwal's Health Balance Sheet

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 249 184 212 630 1339 1867
Minority's Interest 18 14 21 30 40 60
Borrowings 145 168 254 306 310 157
Other Non-Current Liabilities 181 257 318 504 627 1078
Total Current Liabilities 146 150 206 301 400 478
Total Liabilities 740 774 1012 1770 2716 3640
Fixed Assets 551 575 701 1293 1746 2523
Other Non-Current Assets 44 44 83 167 211 322
Total Current Assets 146 154 227 310 759 794
Total Assets 740 774 1012 1770 2716 3640

Dr. Agarwal's Health Cash Flow

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 94 39 55 100 127 112
Cash Flow from Operating Activities 103 99 164 233 346 360
Cash Flow from Investing Activities -80 -37 -155 -509 -914 -750
Cash Flow from Financing Activities -73 -37 35 303 553 382
Net Cash Inflow / Outflow -50 25 44 27 -15 -8
Closing Cash & Cash Equivalent 39 55 100 127 112 104

Dr. Agarwal's Health Ratios

# Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -1 -2.7 1.83 3.96 2.97 2.64
CEPS(Rs) 3.57 1.77 6.84 9.74 9.48 10.8
DPS(Rs) 0 0 0 0 0 0
Book NAV/Share(Rs) 12.1 8.95 10.32 26.4 47.63 58.77
Core EBITDA Margin(%) 23.27 16.29 26.1 26.51 27.18 26.39
EBIT Margin(%) 8.16 -0.9 15.19 15.73 18.1 16.07
Pre Tax Margin(%) -2.04 -10.26 8.15 8.21 10.55 9.34
PAT Margin (%) -3.7 -12.39 6.2 10.14 7.14 6.45
Cash Profit Margin (%) 13.84 7.72 20.23 22.74 19.92 19.93
ROA(%) -2.66 -7.72 4.83 7.42 4.24 3.47
ROE(%) -7.89 -26.95 21.77 24.58 9.69 6.92
ROCE(%) 10.53 -1.09 24.26 21.51 17.77 14.32
Receivable days 36.06 38.4 27.12 23.85 23.72 23.51
Inventory Days 22.99 23.75 15.94 12.36 12.05 14.1
Payable days 340.04 419.56 356.83 306.23 312.42 322
PER(x) 0 0 0 0 0 169.15
Price/Book(x) 0 0 0 0 0 7.6
Dividend Yield(%) 0 0 0 0 0 0
EV/Net Sales(x) 0.23 0.27 0.26 0.21 0.2 8.24
EV/Core EBITDA(x) 0.91 1.4 0.89 0.75 0.66 27.73
Net Sales Growth(%) 0 -11.23 47.73 46.25 30.86 28.44
EBIT Growth(%) 0 -109.84 2580.75 51.37 50.61 14.07
PAT Growth(%) 0 -197.11 173.94 139.16 -7.92 16.09
EPS Growth(%) 0 -170.22 167.94 116.06 -25.01 -10.97
Debt/Equity(x) 0.65 1.01 1.37 0.57 0.29 0.13
Current Ratio(x) 1 1.03 1.1 1.03 1.9 1.66
Quick Ratio(x) 0.77 0.84 0.94 0.91 1.77 1.49
Interest Cover(x) 0.8 -0.1 2.16 2.09 2.4 2.39
Total Debt/Mcap(x) 0 0 0 0 0 0.02

Dr. Agarwal's Health Shareholding Pattern

# Mar 2025 Jun 2025 Sep 2025
Promoter 32.45 32.42 32.42
FII 40.49 39.16 38.03
DII 25.34 26.54 28.03
Public 1.72 1.88 1.52
Others 0 0 0
Total 100 100 100

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 32.42%.
  • Company has a low return on equity of 14% over the last 3 years.
  • Debtor days have increased from 312.42 to 322days.
  • Stock is trading at 8.2 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Dr. Agarwal's Health News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!